首页> 美国政府科技报告 >Inhibition of Carcinogen-Induced Cellular Transformation of Human Fibroblasts by Drugs that Interact with the Poly(ADP-Ribose) Polymerase System
【24h】

Inhibition of Carcinogen-Induced Cellular Transformation of Human Fibroblasts by Drugs that Interact with the Poly(ADP-Ribose) Polymerase System

机译:通过与聚(aDp-核糖)聚合酶系统相互作用的药物抑制致癌物诱导的人成纤维细胞的细胞转化

获取原文

摘要

Two types of interactions of 13 drugs with human fibroblasts were determined: (a) I sub 50 of nuclear poly(ADP-ribose) polymerase,as assayed with isolated nuclei in vitro, and (b) the nontoxic concentration of drugs that prevented carcinogen-induced cell transformation of intact fibroblasts RCF sub 1). In general, RCF sub 1 was much lower than I sub 50, and one antitransformer did not inhibit the enzyme in vitro, indicating that low-affinity enzyme inhibitory sites appear to play no role in the mechanism of prevention of cell transformation. Two enzyme inhibitors, caffeine and 1-methylnicotinamide, exhibited no antitransforming activity. Benzamide when applied in population doubling 1 induced resistance to cell transformation in population doubling 6 by carcinogens added at this stage.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号